Snapshot Study on Patients With Heart Failure
GRASP-HF
Global Registries And Surveys Programme - Heart Failure Snapshot Study (GRASP-HF)
1 other identifier
observational
4,000
0 countries
N/A
Brief Summary
The goal of this observational study is to provide a better understanding of medical practice for heart failure management based on real-world data, collected both across Europe and the rest of the world, using robust methodology and representativeness within each country. Standard management of patients will be the diagnostic and therapeutic interventions routinely performed in each center for patients presenting with signs and symptoms of chronic/acute heart failure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2024
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 17, 2024
CompletedFirst Posted
Study publicly available on registry
June 24, 2024
CompletedStudy Start
First participant enrolled
September 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedJune 24, 2024
June 1, 2024
9 months
June 17, 2024
June 17, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Adherence to ESC Guidelines in Heart Failure 2021
Full adherence to guidelines for heart failure management
12 months per site
Study Arms (2)
Patients with chronic heart failure
Patients with acute heart failure
Eligibility Criteria
The study population is all consenting patients seen in the outpatient clinic for chronic HF and all consenting patients admitted for acute HF in the study center as their standard medical care.
You may qualify if:
- Adult patients with chronic or acute Heart Failure (HF), regardless of ejection fraction, either:
- Outpatient with chronic HF (including first-time diagnosis), according to the clinical judgment.
- Patients admitted to hospital or presenting to Emergency Department or Acute out-patient care for acute HF for whom an IV (diuretics, inotropes, vasodilators) or mechanical therapy for HF (mechanical circulatory support) is administered.
You may not qualify if:
- Age \<18 years
- Patients unwilling to consent (or patient's legally authorized representative unwilling to consent, if the patient is unable to consent).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Ovidiu Chioncel
Institute for Cardiovascular Diseases C.C. Iliescu, Bucaresti, Romania
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 17, 2024
First Posted
June 24, 2024
Study Start
September 1, 2024
Primary Completion
June 1, 2025
Study Completion
June 1, 2025
Last Updated
June 24, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share